These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6140511)

  • 1. Metronidazole or vancomycin for Clostridium difficile associated diarrhoea.
    Gordon RS
    Lancet; 1983 Dec; 2(8364):1417. PubMed ID: 6140511
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Bishara J; Wattad M; Paul M
    Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.
    Teasley DG; Gerding DN; Olson MM; Peterson LR; Gebhard RL; Schwartz MJ; Lee JT
    Lancet; 1983 Nov; 2(8358):1043-6. PubMed ID: 6138597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ; Murdoch DR
    Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
    Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
    J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
    [No Abstract]   [Full Text] [Related]  

  • 7. Managing C. difficile-associated diarrhea.
    Bailey EM
    Am J Health Syst Pharm; 1998 Jul; 55(13):1365. PubMed ID: 9659963
    [No Abstract]   [Full Text] [Related]  

  • 8. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
    Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
    J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of outcomes with vancomycin or metronidazole for mild-to-moderate Clostridium difficile associated diarrhea among solid organ transplant recipients: A retrospective cohort study.
    Nguyen CT; Li J; Anders S; Garcia-Diaz J; Staffeld-Coit C; Hand J
    Transpl Infect Dis; 2018 Jun; 20(3):e12867. PubMed ID: 29512244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile-associated disease treatment response depends on definition of cure.
    Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
    Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
    [No Abstract]   [Full Text] [Related]  

  • 11. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
    Wilcox MH; Howe R
    J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients.
    Parks T; Wallis S; Wilson J; Gkrania-Klotsas E; Nicholl C
    J Hosp Infect; 2010 Apr; 74(4):403-5. PubMed ID: 20153080
    [No Abstract]   [Full Text] [Related]  

  • 14. The Rise and Fall of Metronidazole for Clostridium difficile Infection.
    Chahine EB
    Ann Pharmacother; 2018 Jun; 52(6):600-602. PubMed ID: 29424238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.
    Delmée M; Melin P; Peetermans W; Verbist L; Verschraegen G
    Acta Clin Belg; 1995; 50(2):114-6. PubMed ID: 7597874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating C. difficile.
    Parmar MS
    CMAJ; 2005 Feb; 172(4):448; author reply 448. PubMed ID: 15710921
    [No Abstract]   [Full Text] [Related]  

  • 17. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
    Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
    Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral metronidazole in Clostridium difficile colitis.
    Mogg GA; Burdon DW; Keighley M
    Br Med J; 1979 Aug; 2(6185):335. PubMed ID: 476461
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial Commentary: the trials and tribulations of treating Clostridium difficile infection-one step backward, one step forward, but still progress.
    Wilcox MH
    Clin Infect Dis; 2014 Aug; 59(3):355-7. PubMed ID: 24799325
    [No Abstract]   [Full Text] [Related]  

  • 20. Fidaxomicin in the treatment of Clostridium difficile infection in oncohematology patients.
    Martín Rizo L; Malpartida Flores M; Fernández Lisón LC
    Med Clin (Barc); 2019 Oct; 153(7):298-299. PubMed ID: 30337114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.